Latest Insider Transactions at Igm Biosciences, Inc. (IGMS)
This section provides a real-time view of insider transactions for Igm Biosciences, Inc. (IGMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IGM Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IGM Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2024
|
Mary Beth Harler Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
185,000
+34.66%
|
-
|
|
Sep 30
2024
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+15.68%
|
-
|
|
Sep 30
2024
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,734
+0.06%
|
-
|
|
Sep 30
2024
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+5.2%
|
-
|
|
Sep 30
2024
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+1.93%
|
-
|
|
Sep 30
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
3,078
+15.96%
|
-
|
|
Sep 30
2024
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+25.0%
|
-
|
|
Sep 30
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
3,988
+0.31%
|
-
|
|
Sep 13
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,487
-1.2%
|
$16,357
$11.54 P/Share
|
|
Sep 13
2024
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,487
-0.95%
|
$16,357
$11.54 P/Share
|
|
Sep 13
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
469
-1.8%
|
$5,159
$11.54 P/Share
|
|
Sep 13
2024
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,487
-0.61%
|
$16,357
$11.54 P/Share
|
|
Sep 13
2024
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,946
-1.55%
|
$43,406
$11.54 P/Share
|
|
Sep 13
2024
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
925
-1.16%
|
$10,175
$11.54 P/Share
|
|
Sep 13
2024
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,487
-0.9%
|
$16,357
$11.54 P/Share
|
|
Aug 08
2024
|
William Strohl |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+50.0%
|
-
|
|
Jul 25
2024
|
Julie Hambleton |
SELL
Open market or private sale
|
Direct |
15,132
-88.33%
|
$211,848
$14.0 P/Share
|
|
Jul 25
2024
|
Julie Hambleton |
BUY
Exercise of conversion of derivative security
|
Direct |
15,132
+46.9%
|
$15,132
$1.39 P/Share
|
|
Jul 19
2024
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
46,666
+8.25%
|
-
|
|
Jul 19
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
35,333
+11.56%
|
-
|
|
Jul 19
2024
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+16.65%
|
-
|
|
Jul 19
2024
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+10.93%
|
-
|
|
Jul 19
2024
|
Mary Beth Harler Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+20.66%
|
-
|
|
Jun 28
2024
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+18.6%
|
-
|
|
Jun 28
2024
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,734
+0.06%
|
-
|
|
Jun 28
2024
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+1.96%
|
-
|
|
Jun 28
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
3,078
+19.0%
|
-
|
|
Jun 28
2024
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+33.33%
|
-
|
|
Jun 28
2024
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+5.49%
|
-
|
|
Jun 28
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
3,988
+0.31%
|
-
|
|
Jun 14
2024
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
495
-1.87%
|
$3,465
$7.58 P/Share
|
|
Jun 14
2024
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,570
-1.81%
|
$10,990
$7.58 P/Share
|
|
Jun 14
2024
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,106
-0.56%
|
$7,742
$7.58 P/Share
|
|
Jun 14
2024
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,164
-1.61%
|
$29,148
$7.58 P/Share
|
|
Jun 14
2024
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,570
-1.74%
|
$10,990
$7.58 P/Share
|
|
Jun 14
2024
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,570
-1.61%
|
$10,990
$7.58 P/Share
|
|
Jun 14
2024
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
977
-1.6%
|
$6,839
$7.58 P/Share
|
|
May 15
2024
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.49%
|
$15,000
$5.02 P/Share
|
|
May 15
2024
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+1.15%
|
$15,000
$5.02 P/Share
|
|
May 15
2024
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+2.99%
|
$15,000
$5.02 P/Share
|
|
Mar 29
2024
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+22.85%
|
-
|
|
Mar 29
2024
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,452
+50.0%
|
-
|
|
Mar 29
2024
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
2,687
+5.8%
|
-
|
|
Mar 29
2024
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+2.0%
|
-
|
|
Mar 29
2024
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
3,078
+23.45%
|
-
|
|
Mar 29
2024
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,734
+0.06%
|
-
|
|
Mar 29
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
3,988
+0.31%
|
-
|
|
Mar 28
2024
|
Redmile Group, LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
12,464
-0.4%
|
-
|
|
Mar 28
2024
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
97,473
+2.3%
|
$877,257
$9.62 P/Share
|
|
Mar 27
2024
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
27,844
+0.34%
|
$250,596
$9.25 P/Share
|